Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
150
days
CircZBTB46, a promising therapeutic target in crizotinib resistant ALK-positive T lymphomas
Authors
Loélia Babin; Elissa Andraos; Steffen Fuchs; Chloe Bessière; Lola Colras; Sandra Dailhau; Cathy Quelen; Cindy Pinto; Iyad Daoudi; Romain Pfeifer; Ahmed Zamani; Marina Bousquet; Stéphane Pyronnet; Christine Gaspin; Laurence Lamant; Fabienne MeggettoShow moreShow less
Affiliations
1. Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Institut Universitaire du Cancer, Toulouse, France; 2. Laboratoire d’Excellence Toulouse Cancer-TOUCAN, Toulouse, France; 3. Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin, Corporate Member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany; 4. German Cancer Consortium (DKTK), Partner Site Berlin, a Partnership Between DKFZ and Charité-Universitätsmedizin, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany; 5. INRAE, BioinfOmics, GenoToul Bioinformatics Facility, Université de Toulouse, Castanet-Tolosan, Toulouse, France; 6. INRAE, MIAT, Université de Toulouse, Castanet-Tolosan, Toulouse, FranceShow moreShow less
184
days
MYD88 variants in chronic lymphocytic leukemia exhibit distinct biological behaviors and prognostic implications
Authors
Yuting Yan; Yulan Zhou; Weihao Chen; Jun Wang; Tingyu Wang; Ying Yu; Wenjie Xiong; Yujiao Jia; Zhen Yu; Dehui Zou; Gang An; Lugui Qiu; Fei Li; Shuhua YiShow moreShow less
Affiliations
1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China; 2. Tianjin Institutes of Health Science, Tianjin, China; 3. Jiangxi Provincial Key Laboratory of Hematological Diseases, Department of Hematology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China; 4. Institute of Hematology, Academy of Clinical Medicine of Jiangxi Province, Nanchang, ChinaShow moreShow less
225
days
Small interfering RNA-mediated silencing of mutant NPM1 suppresses acute myeloid leukemia via reversing KAT7 and p300-mediated histone acetylation
Authors
Yongqiang Hou; Yunzhi Xing; Chunjie Chen; Dongxue Su; Zhien Zhou; Yi Ye; Zhangjian Lai; Zhixian Peng; Hongxi Cai; Min Sun; Yue Liu; Bingying Yang; Haitao Huang; Zhe Li; Jinhuan Li; Junhong Li; Huan Gao; Jiaxin Li; Hao Zhao; Yiran Shi; Qinghua Chen; Jun Long; Jiong Hu; Dawang Zhou; Lanfen ChenShow moreShow less
Affiliations
1. State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiang’an Hospital, Xiang An Biomedicine Laboratory, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, China; 2. Department of Hematology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China; 3. Shanghai Institute of Hematology Blood & Marrow Transplantation Center, Department of Hematology, Collaborative Innovation Center of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
